Mapping cancer cell metabolism with 13 C flux analysis: Recent progress and future challenges

Journal of Carcinogenesis

Volumn 12, Issue , 2013, Pages

  Duckwall, Casey ^a   Murphy, Taylor ^a   Young, Jamey ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Aerobic glycolysis; isotopomer analysis; metabolomics; reductive carboxylation; warburg effect

Indexed keywords

CARBON 13;

ARTICLE; BIOSYNTHESIS; CANCER CELL; CELL METABOLISM; ENVIRONMENTAL FACTOR; GENE FUNCTION; GENETIC ENGINEERING AND GENE TECHNOLOGY; HUMAN; ISOTOPE TRACING; METABOLIC FLUX ANALYSIS; ONCOGENE; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 84893088514     PISSN: 09746773     EISSN: 14773163     Source Type: Journal    
DOI: 10.4103/1477-3163.115422     Document Type: Article

References (51)

1. Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011;11:325-37.
2. Kim JW, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 2006;66:8927-30. (Pubitemid 44521105)
3. Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006;9:425-34. (Pubitemid 43832190)
4. Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA 2010;107:2037-42.
5. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008;452:230-3. (Pubitemid 351380249)
6. DeBerardinis RJ, Cheng T. Q's next: The diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 2010;29:313-24.
7. Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011;476:346-50.
8. Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 2011;43:869-74.
9. Jain M, Nilsson R, Sharma S, Madhusudhan N, Kitami T, Souza AL, et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 2012;336:1040-4.
10. Reitman ZJ, Yan H. Isocitrate dehydrogenase 1 and 2 mutations in cancer: Alterations at a crossroads of cellular metabolism. J Natl Cancer Inst 2010;102:932-41.
11. Dang L, Jin S, Su SM. IDH mutations in glioma and acute myeloid leukemia. Trends Mol Med 2010;16:387-97.
12. Toro JR, Nickerson ML, Wei MH, Warren MB, Glenn GM, Turner ML, et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 2003;73:95-106. (Pubitemid 36793783)
13. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001;69:49-54. (Pubitemid 32614017)
14. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011;144:646-74.
15. Sauer U. Metabolic networks in motion: 13C-based flux analysis. Mol Syst Biol 2006;2:62.
16. Niklas J, Heinzle E. Metabolic flux analysis in systems biology of mammalian cells. Adv Biochem Eng Biotechnol 2012;127:109-32.
17. Gomes LC, Simões M. C metabolic flux analysis: From the principle to recent applications. Curr Bioinform 2012;7:77-86.
18. Winter G, Krömer JO. Fluxomics-connecting 'omics analysis and phenotypes. Environ Microbiol 2013;doi:10.1111/1462-2920.12064.
19. Quek LE, Dietmair S, Krömer JO, Nielsen LK. Metabolic flux analysis in mammalian cell culture. Metab Eng 2010;12:161-71.
20. Zamboni N, Fendt SM, Rühl M, Sauer U.(13) C-based metabolic flux analysis. Nat Protoc 2009;4:878-92.
21. Zamboni N. 13C metabolic flux analysis in complex systems. Curr Opin Biotechnol 2011;22:103-8.
22. Roche TE, Hiromasa Y. Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer. Cell Mol Life Sci 2007;64:830-49. (Pubitemid 46597752)
23. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006;3:177-85.
24. Mazurek S, Boschek CB, Hugo F, Eigenbrodt E. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 2005;15:300-8. (Pubitemid 41058775)
25. Luo W, Hu H, Chang R, Zhong J, Knabel M, O'Meally R, et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 2011;145:732-44.
26. Wu S, Le H. Dual roles of PKM2 in cancer metabolism. Acta Biochim Biophys Sin (Shanghai) 2013;45:27-35.
27. Ye J, Mancuso A, Tong X, Ward PS, Fan J, Rabinowitz JD, et al. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci USA 2012;109:6904-9.
28. Grassian AR, Metallo CM, Coloff JL, Stephanopoulos G, Brugge JS. Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. Genes Dev 2011;25:1716-33.
29. Wise DR, Thompson CB. Glutamine addiction: A new therapeutic target in cancer. Trends Biochem Sci 2010;35:427-33.
30. DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, et al. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 2007;104:19345-50.
31. Metallo CM, Walther JL, Stephanopoulos G. Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells. J Biotechnol 2009;144:167-74.
32. Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 2011;481:380-4.
33. Scott DA, Richardson AD, Filipp FV, Knutzen CA, Chiang GG, Ronai ZA, et al. Comparative metabolic flux profiling of melanoma cell lines: Beyond the Warburg effect. J Biol Chem 2011;286:42626-34.
34. Wise DR, Ward PS, Shay JE, Cross JR, Gruber JJ, Sachdeva UM, et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci USA 2011;108:19611-6.
35. Mullarky E, Mattaini KR, Vander Heiden MG, Cantley LC, Locasale JW. PHGDH amplification and altered glucose metabolism in human melanoma. Pigment Cell Melanoma Res 2011;24:1112-5.
36. Pollari S, Käkönen SM, Edgren H, Wolf M, Kohonen P, Sara H, et al. Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis. Breast Cancer Res Treat 2011;125:421-30.
37. Bos JL. Ras oncogenes in human cancer: A review. Cancer Res 1989;49:4682-9. (Pubitemid 19213607)
38. Bossù P, Vanoni M, Wanke V, Cesaroni MP, Tropea F, Melillo G, et al. A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblasts. Oncogene 2000;19:2147-54. (Pubitemid 30251380)
39. Ying H, Kimmelman AC, Lyssiotis CA, Hua S, Chu GC, Fletcher-Sananikone E, et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 2012;149:656-70.
40. Gaglio D, Metallo CM, Gameiro PA, Hiller K, Danna LS, Balestrieri C, et al. Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol Syst Biol 2011;7:523.
41. Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 2013;496:101-5.
42. Murphy TA, Dang CV, Young JD. Isotopically nonstationary 13C flux analysis of Myc-induced metabolic reprogramming in B-cells. Metab Eng 2013;15:206-17.
43. Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab 2012;15:110-21.
44. Forbes NS, Meadows AL, Clark DS, Blanch HW. Estradiol stimulates the biosynthetic pathways of breast cancer cells: Detection by metabolic flux analysis. Metab Eng 2006;8:639-52. (Pubitemid 44515198)
45. Weitzel M, Nöh K, Dalman T, Niedenführ S, Stute B, Wiechert W. 13CFLUX2: High-performance software suite for (13) C-metabolic flux analysis. Bioinformatics 2013;29:143-5.
46. Quek LE, Wittmann C, Nielsen LK, Krömer JO. Open FLUX: Efficient modelling software for 13C-based metabolic flux analysis. Microb Cell Fact 2009;8:25.
47. Srour O, Young JD, Eldar YC. Fluxomers: A new approach for 13C metabolic flux analysis. BMC Syst Biol 2011;5:129.
48. Murphy TA, Young JD. ETA: Robust software for determination of cell specific rates from extracellular time courses. Biotechnol Bioeng 2013;110:1748-58.
49. Kim BJ, Forbes NS. Flux analysis shows that hypoxia-inducible-factor-1- alpha minimally affects intracellular metabolism in tumor spheroids. Biotechnol Bioeng 2007;96:1167-82. (Pubitemid 46648675)
50. Yuneva MO, Fan TW, Allen TD, Higashi RM, Ferraris DV, Tsukamoto T, et al. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab 2012;15:157-70.
51. Marin-Valencia I, Yang C, Mashimo T, Cho S, Baek H, Yang XL, et al. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab 2012;15:827-37.